Management of Persistent Cough
All patients with persistent cough (>8 weeks) require chest radiograph and spirometry as mandatory baseline investigations, followed by systematic evaluation and treatment of the most common causes: upper airway cough syndrome (UACS), asthma, gastroesophageal reflux disease (GERD), and nonasthmatic eosinophilic bronchitis (NAEB). 1
Initial Assessment and Red Flags
Immediately assess for life-threatening conditions before proceeding with chronic cough evaluation:
- Hemoptysis, fever, night sweats, weight loss, or history of tuberculosis, cancer, or AIDS require urgent expanded workup 2
- In smokers, examine specifically for finger clubbing combined with pleural effusion or lobar collapse—this strongly suggests bronchogenic carcinoma 1, 2
- Cough is the fourth most common presenting feature of lung cancer 2
- Discontinue ACE inhibitors immediately in all patients with troublesome cough—no patient should continue these medications 1
Mandatory Baseline Investigations
Chest radiograph is required in all patients with chronic cough:
- Approximately 31% of chest radiographs will be abnormal or yield a diagnosis 1, 2
- If abnormal findings account for symptoms, investigate appropriately rather than using chronic cough algorithms 1
Spirometry with bronchodilator response testing is mandatory:
- Measure FEV1 before and after short-acting β2-agonist (salbutamol 400 mcg by MDI with spacer or 2.5 mg by nebulizer) 1
- Critical pitfall: Normal spirometry does NOT exclude asthma or eosinophilic bronchitis as causes 1, 2
- Do NOT use single peak flow measurements—they are less accurate than FEV1 for identifying airflow obstruction 1, 2
Sequential Treatment Algorithm
Step 1: Upper Airway Cough Syndrome (UACS)
Treat first for UACS (formerly postnasal drip syndrome), as this is one of the three most common causes:
- In the presence of prominent upper airway symptoms, prescribe topical intranasal corticosteroid (fluticasone or mometasone) 1, 3
- Add first-generation antihistamine/decongestant combination (brompheniramine/pseudoephedrine or chlorpheniramine/phenylephrine) 3
- Start once-daily at bedtime for 2-3 days, then advance to twice-daily to minimize sedation 3
- Critical warning: Do NOT use nasal decongestant sprays for more than 3-5 days due to rebound congestion risk 3
Step 2: Asthma/NAEB Evaluation
If UACS treatment fails after 2 weeks, proceed to asthma evaluation:
- Bronchial provocation testing should be performed in patients without clinically obvious etiology who have normal spirometry 1
- If bronchial provocation testing is unavailable and baseline spirometry is normal, initiate empiric asthma treatment 1
For confirmed or suspected asthma:
- Begin with inhaled β2-agonists and inhaled corticosteroids 1
- If inadequate response, patients with normal spirometry and bronchodilator response should be offered a therapeutic trial of oral prednisolone for 2 weeks 1
- Cough is unlikely to be due to eosinophilic airway inflammation if there is no response to a 2-week oral steroid trial 1
- Consider adding leukotriene inhibitor before oral corticosteroid 1
For NAEB diagnosis:
- Induced sputum test to determine increased eosinophils is the diagnostic test of choice 1
- NAEB should be considered after UACS and asthma because diagnosis is straightforward and response to treatment is very predictable 1
Step 3: Gastroesophageal Reflux Disease (GERD)
If cough persists after adequate trials of UACS and asthma treatment, evaluate for GERD:
- Critical point: Failure to consider GERD as a cause for cough is a common reason for treatment failure 1
- Reflux-associated cough may occur in the absence of gastrointestinal symptoms 1
Empiric GERD treatment is recommended for patients with this clinical profile:
- Cough >2 months, normal chest radiograph, nonsmoker, not on ACE inhibitors, failed UACS and asthma treatment 1
- This profile has 92% probability of GERD-induced cough 1
GERD treatment protocol:
- Intensive acid suppression with high-dose proton pump inhibitors (omeprazole 40 mg twice daily) and alginates should be undertaken for a minimum of 3 months 1, 3
- Add dietary modifications and lifestyle changes 3
- Critical timing issue: GERD-related cough may require 2 weeks to several months for response, with some patients needing 8-12 weeks 3, 2
- If inadequate response, add prokinetic agent (metoclopramide) and rigorous adherence to dietary measures 1
For patients without GERD symptoms:
- Ideally perform 24-hour esophageal pH monitoring, though interpretation criteria vary 1
- Given limited availability and interpretation issues, empiric trial of antireflux therapy is reasonable 1
Step 4: Advanced Evaluation for Refractory Cough
If all empiric treatments fail after adequate trials (minimum 3 months for GERD), proceed with advanced testing:
- High-resolution CT chest to evaluate for bronchiectasis, interstitial lung disease, or occult masses 1, 3, 2
- 24-hour esophageal pH monitoring if GERD remains suspected despite failed empiric therapy 3, 2
- Bronchoscopy should be undertaken in all patients in whom inhalation of a foreign body is suspected 1
- Bronchoscopy may be useful to evaluate for endobronchial tumor, sarcoidosis, suppurative lower airway infection, eosinophilic or lymphocytic bronchitis 1, 3, 2
In countries where tuberculosis is common:
- Obtain expectorated or induced sputum samples with acid-fast staining or bronchoscopy to detect occult endobronchial tuberculosis 1
Special Considerations
Post-Infectious Cough (Subacute Cough)
If cough duration is 2-8 weeks following respiratory infection:
- Prescribe inhaled ipratropium bromide 2-3 puffs four times daily—this has the strongest evidence for attenuating post-infectious cough 3, 2
- Provide reassurance that post-infectious cough typically resolves spontaneously within 3-8 weeks total from symptom onset 2
- Do NOT prescribe antibiotics unless bacterial sinusitis or pertussis is confirmed 2
Pertussis Evaluation
If paroxysmal cough, post-tussive vomiting, or inspiratory whooping sound present:
- Pertussis must be ruled out first, even in vaccinated patients, as breakthrough infections occur 3
- Obtain nasopharyngeal culture for Bordetella pertussis 3, 2
- If pertussis is confirmed or highly suspected, prescribe macrolide antibiotics immediately (azithromycin or clarithromycin) 3
- Pertussis accounts for approximately 10% of chronic cough cases in some series 2
Smoking-Related Cough
Smoking is one of the commonest causes of persistent cough and appears dose-related:
- Smoking cessation should be encouraged as it is accompanied by significant remission in cough symptoms 1
Refractory/Unexplained Chronic Cough
Before diagnosing unexplained cough:
- Chronic cough should only be considered idiopathic following thorough assessment at a specialist cough clinic 1
- Do NOT diagnose "unexplained cough" until completing systematic evaluation of UACS, asthma, and GERD with adequate treatment trials 3
- Referral to a specialist cough clinic should be encouraged 1
For confirmed refractory chronic cough:
- Consider gabapentin trial starting at 300 mg once daily, escalating as tolerated to maximum 1,800 mg daily in divided doses 2
- Multimodality speech pathology therapy is a reasonable alternative 2
- Low-dose morphine may be considered but carries addiction risk 2
Critical Pitfalls to Avoid
- Do NOT continue ACE inhibitors in any patient with troublesome cough 1
- Do NOT use single peak flow measurements for diagnosis 1, 2
- Do NOT abandon GERD therapy prematurely—it may require 8-12 weeks for response 2
- Do NOT inappropriately prescribe antibiotics for non-bacterial post-infectious cough 2
- Do NOT assume GERD is ruled out simply because of prior antireflux surgery, as reflux can persist 3
- Do NOT fail to recognize that more than one cause may be present simultaneously—sequential and additive therapy may be crucial 1
Treatment Monitoring
Treatment effects should be formally quantified using:
- Cough-specific quality of life questionnaires 1
- Cough visual analogue scores as an alternative, though less well validated 1
Optimal management comprises a combination of diagnostic testing and treatment trials based on the most probable causes, with formal quantification of treatment effects. 1